What is the market size of the APAC cell counting market?
Asia
Pacific Cell Counting Market Highlights
Cell
counting market is expected to witness growth in future as it has wide range of
applications in research institutes, hospitals, biotechnology and
pharmaceuticals companies and it an important tool in research, drug discovery
and biopharmaceutical applications. Increasing prevalence of cancer and rising
geriatric population are major driver for the market growth.
Furthermore, factors responsible for the growth of the cell counting
market in Asia Pacific are rising awareness regarding prevalence of
disease such as cancer and other lifestyle diseases and improvement in
healthcare facilities. High cost of cell counting instruments may create an
obstacle for the market growth.
The Asia Pacific cell counting market is anticipated to reach USD 180 Million by 2030 at
9.50% CAGR during the forecast period 2022-2030.
Taste
the market data and market information presented through more than 22 market
data tables and figures spread over 50 numbers of pages of the project report.
Avail the in-depth table of content TOC & market synopsis on “Cell Counting
Market Research Report– Asia Pacific Forecast till 2030.”
Segmentation:
The
Asia Pacific cell counting market is segmented on the basis on instruments used
for cell counting which are spectrophotometer, cell counter, haemocytometer,
flow cytometer, haematology analysers, microscope, and other instruments. Based
on application of cell counting which includes cell structure study and cell
analysis, quality control, cell viability, proliferation, signalling,
identification, single cell analysis and other applications. It is also
segmented based on its end users which are hospitals, research institutes,
pharmaceutical and biotechnology companies, clinical research organizations and
other end users.
Regional
Analysis:
Asia Pacific cell counting market report consists of countries
namely China, Japan, Republic of Korea, India, Australia, and
Rest of Asia Pacific. Japan is the largest market for cell
counting due to an increase in prevalence of cancer and demand for
new cell counting techniques.
China
and Japan are major manufacturers of medical devices. In China, factors
responsible for the market growth are rising geriatric population with chronic
diseases, increasing experimental use of cell counting devices, and
availability of low-cost diagnostic and treatment options.
Rising
number of diagnostic canters, growing emphasis of cell counting for the
diagnosis of chronic diseases and overall growth of diagnostic services drive
the market in India. Lack of awareness about the available diagnostic services
also boost the market growth.
Australia
and Republic of Korea show slow growth in cell counting market.
Market
Players:
Key
players in cell counting market are Bio-Rad Laboratories
Inc. (U.S), General Electric Company (U.S), Agilent Technologies
(U.S), PerkinElmer Inc. (U.S), Tecan Trading AG (Switzerland), BioTek
Instruments, Inc. (U.S), Danaher (U.S), Merck KGaA (U.S).
About Market
Research Future:
At Market Research
Future (MRFR), we enable our customers to unravel the complexity of various
industries through our Cooked Research Report (CRR), Half-Cooked Research
Reports (HCRR), & Consulting Services. MRFR team have supreme objective to
provide the optimum quality market research and intelligence services to our
clients.
Contact us:
Market Research
Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,
5Th Floor,
New York, New York
10013
United States of
America
+1 628 258 0071
Email: sales@marketresearchfuture.com
Comments
Post a Comment